Clinical outcome of ticagrelor in therapy patients with acute ST-segment elevation myocardial infarc

来源 :第十二届中国介入心脏病学大会(CIT2014) | 被引量 : 0次 | 上传用户:liutongyang123
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background To identify clinic outcome of ticagrelor in therapy patients with acute ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention.Methods Sixty-two consecutive patients with STEMI receiving primary PCI were included in this study.The clinic characteristics,TIMI refuse after PCI,clinical outcomes after 30 days of patients were compared between patients treatment with ticagrelor (group A 30 cases) and clopidogrel (group B 32 cases).
其他文献
Background Long interspersed nucleotide element-1 (LINE-l) is a retroelement comprising about 17% of the human genome.DNA methylation in LINE-1 repetitive element is a surrogate marker of global DNA m
会议
Background To study the Heart rate turbulence correlate with extent of coronary artery disease and cardiac function in patients with coronary heart disease Methods We selected 60 patients who had unde
会议
Background To evaluate the effect of PCI in the patients who get the anterior myocardial infarction with ventricular aneurysm and the change of N-terminal B-type natriuretic peptide (BNP),serum high-s
会议
Background Dual antiplatelet therapy is the standard treatment after coronary stenting.CYP2C19 is the key enzyme of biological metabolism to oxidize clopidogrel.The aim of our study is to investigate
会议
Background It has been reported that fragmented QRS (fQRS) complexes was associated with increased morbidity and mortality,sudden cardiac death and recurrent cardiovascular events.A well-grown coronar
会议
Background To evaluate the long-term efficacy and safety of Cypher and Taxus stents,after more than 8 years of the stents implantation in daily practice.Methods From April 2004 to April 2005,682 conse
会议
Background LDL-C is primary treatment target for patients with dislipidemia.The apo B,an emerging biomarker for cardiovascular risk prediction,appears to be superior to the LDL-C.However,little is kno
会议
Background Non ST-elevation acute myocardial infarction patients have a wide variation in their disease severity and clinical presentations.Therefore,Risk stratification is very important to obtain cl
会议
Background Myocardial necrosis following STEMI causes left ventricular systolic dysfunction,decreased LV systolic function has been associated with poor clinical outcomes,Some studies report that wome
会议
Background Coronary atherosclerotic heart disease (CAD) is an important prognostic factor in patients with systemic lupus erythematosus (SLE).Most studies on lupus premature coronary heart disease fai
会议